Originally published by our sister publication Specialty Pharmacy Continuum
By Myles Starr
High demand and short supply of medications known as GLP-1 (glucagon-like peptide-1) antagonists used to treat diabetes and obesity have led many people desperate for these drugs to online marketplaces that operate further from scrutiny than brick-and-mortar retail pharmacies. Consequently, the FDA is taking steps to stem the illicit trade in unapproved, mislabeled and sometimes harmful drugs offered by